SCHEMBL29540237

SCHEMBL29540237

c1cncc(-c2ccnc(NC3CCC(N4CCCC4)CC3)n2)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 3/20 0.52
EGFR P00533 2/20 0.52
PRKCA P17252 1/20 0.52
PRKCD Q05655 1/20 0.52
HDAC8 Q9BY41 6/20 0.48
HDAC6 Q9UBN7 4/20 0.48
HDAC1 Q13547 3/20 0.48
HDAC7 Q8WUI4 1/20 0.48
HDAC9 Q9UKV0 1/20 0.48
CDK4 P11802 2/20 0.47
GSK3B P49841 2/20 0.47
CDK2 P24941 1/20 0.47
ACVR1 Q04771 1/20 0.47
BCR P11274 2/20 0.46
SRC P12931 2/20 0.46
PRKACA P17612 1/20 0.46
PRKACG P22612 1/20 0.46
PRKACB P22694 1/20 0.46
IKBKB O14920 3/20 0.46
DRD2 P14416 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29539927 0.82 IKBKB (0.67) ABL1EGFRPRKCAPRKCDHDAC8
SCHEMBL27739764 0.81 HDAC8 (0.54) ABL1EGFRPRKCAPRKCDHDAC8
SCHEMBL27739765 0.81 ABL1 (0.53) ABL1EGFRPRKCAPRKCDHDAC8
SCHEMBL29540283 0.80 IKBKB (0.65) ABL1EGFRPRKCAPRKCDHDAC8
SCHEMBL29540438 0.79 IKBKB (0.71) ABL1EGFRPRKCAPRKCDHDAC8
SCHEMBL4377891 0.76 DGAT1 (0.51) ABL1EGFRPRKCAPRKCDHDAC8
SCHEMBL30565323 0.76 PRKCZ (0.52) ABL1EGFRPRKCAPRKCDHDAC8
SCHEMBL21621267 0.74 IKBKB (0.59) HDAC8HDAC6CDK4GSK3BCDK2
SCHEMBL30299645 0.74 IKBKB (0.59) HDAC8HDAC6CDK4GSK3BCDK2
SCHEMBL1088926 0.73 HRH4 (0.61) CDK4GSK3BCDK2DRD2DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110418789-B Derivatives of N-cycloalkyl/heterocycloalkyl-4- (imidazo [1,2-a ] pyridine) pyrimidin-2-amines as therapeutic agents 常州千红生化制药股份有限公司 2022-03-25 CN disclosed